Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Study Concerning the Safety for Heart and Brain

Last updated: January 21, 2025
Sponsor: University Hospital, Antwerp
Overall Status: Completed

Phase

N/A

Condition

Aneurysm

Abnormal Blood Vessels (Arteriovenous Malformations)

Treatment

No rapid ventricular pacing

Rapid ventricular pacing

Clinical Study ID

NCT03184233
17/16/205
  • Ages > 18
  • All Genders

Study Summary

Rapid ventricular pacing (RVP) is a technique to obtain flow arrest for short periods of time during dissection or rupture of the aneurysm. RVP results in an adequate fall in blood pressure which presents as an on-off phenomenon. However it is not clear whether repetitive periods of pacing are harmless for the patient. Silent cardiac and cerebral infarcts may be undetected. The investigators will study the safety of RVP, particularly for the heart and the brain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • elective cerebral aneurysm clipping surgery

  • arteriovenous malformation surgery

  • craniotomy

  • American Society of Anesthesiologists 1,2 and 3

Exclusion

Exclusion Criteria:

  • cardiac abnormalities

  • coronary heart disease

  • valvular heart disease

  • pregnancy

Study Design

Total Participants: 59
Treatment Group(s): 2
Primary Treatment: No rapid ventricular pacing
Phase:
Study Start date:
June 14, 2017
Estimated Completion Date:
January 17, 2025

Study Description

Rapid ventricular pacing (RVP) is a technique to obtain flow arrest for short periods of time during dissection or rupture of the aneurysm. RVP results in an adequate fall in blood pressure which presents as an on-off phenomenon. The technique facilitates the dissection and manipulation of cerebral aneurysms and arteriovenous malformations (AVMs) and can be lifesaving in the case of an intraoperative bleeding or rupture. In a former study blood pressure and clinical outcome were used as study parameters. However it is not clear whether repetitive periods of pacing are harmless for the patient. Silent cardiac and cerebral infarcts may be undetected if only clinical outcome is taken as a study parameter. The investigators will study the safety of RVP, particularly for the heart and the brain, using magnetic resonance imaging, brain oxygenation (Sct O₂) evaluated by near-infrared spectroscopy and troponin levels. The purpose of this study is to evaluate the effect of repetitive periods of RVP on the oxygenation of the heart and brain using magnetic resonance imaging, Sct O2 (3) and troponin levels (4) both markers for ischemia damage.

Connect with a study center

  • University hospital Antwerp

    Edegem, Antwerp 2650
    Belgium

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.